Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $8.35 and traded as low as $7.39. Hypera shares last traded at $7.46, with a volume of 4,297 shares changing hands.
Hypera Trading Up 1.9 %
The company has a fifty day moving average of $8.35 and a two-hundred day moving average of $8.22.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- What Are Dividend Challengers?
- Nursing Home REITs: The Surprise Heroes of High Yield Investing
- Are Penny Stocks a Good Fit for Your Portfolio?
- Energy Stocks Shine as High Oil Prices Boost Dividend Yields
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
